Aortic valve sclerosis as a marker of atherosclerosis: Novel insights from hepatic steatosis

International Journal of Cardiology

20 May May 2016 6 months ago
  • Di Minno MN, Di Minno A, Songia P, Tremoli E, Poggio P

Nowadays, aortic valve sclerosis (AVSc) might be considered an atherosclerosis-like process due to significant association with age, male gender and some major features of metabolic syndrome. Nonalcoholic fatty liver disease (NAFLD) has been recognized as a clinical expression of the metabolic syndrome and as a predictor of cardiovascular events. We aim, with this meta-analysis, to evaluate the correlation between NAFLD and AVSc; this finding might suggest new insights and interactions among NAFLD, AVSc and the atherosclerotic process.

Reference
Di Minno MN, Di Minno A, Ambrosino P, Songia P, Tremoli E, Poggio P. Aortic valve sclerosis as a marker of atherosclerosis: Novel insights from hepatic steatosis. Int J Cardiol 2016;217:1-6

Go to PubMed